|
ECPA Welcomes EFSA's Scientific Input but sees it as Late and Fears ED Rules will Crush Innovation in Farm Inputs
|
Wed Mar 20 2013, 10:05 ET
|
|
Quantel Medical Receives FDA Clearance for new Vitra Multispot Laser System
|
Wed Mar 20 2013, 8:00 ET
|
|
Mylan Launches Generic Version of Xopenex® Inhalation Solution
|
Mon Mar 18 2013, 11:04 ET
|
|
A Revolutionary Treatment for Burns & Bone Fractures
|
Mon Mar 18 2013, 10:15 ET
|
|
Anavex comments on FDA plan to expedite approval of new Alzheimer's drugs
|
Mon Mar 18 2013, 9:00 ET
|
|
Medigus Signed a Distribution Agreement in China
|
Mon Mar 18 2013, 9:00 ET
|
|
EAS Consulting Group, Experts in Quality Regulatory Services Related to FDA Issues, Announces Upcoming Dietary Supplement Seminars in Salt Lake City
|
Mon Mar 18 2013, 8:35 ET
|
|
Quidel and Life Technologies Receive FDA Clearance for Clostridium difficile Assay and QuantStudio™ Dx and 7500 Fast Dx Real-Time PCR Instruments
|
Mon Mar 18 2013, 8:00 ET
|
|
ThromboGenics' JETREA® Granted EU Approval for Vitreomacular Traction (VMT), Including When Associated With Macular Hole of Diameter Less Than or Equal to 400 Microns
|
Fri Mar 15 2013, 9:01 ET
|
|
Par Pharmaceutical Begins Shipment of Generic Luvox CR®
|
Thu Mar 14 2013, 9:15 ET
|
|
Neuralstem CEO, Richard Garr, Named To "Top 50 Global Stem Cell Influencers"
|
Thu Mar 14 2013, 9:02 ET
|
|
FDA Sets 26 August 2013 As New PDUFA Date For MOXDUO® NDA
|
Thu Mar 14 2013, 9:00 ET
|
|
Medigus Announces $8 Million Private Placement to OrbiMed
|
Wed Mar 13 2013, 13:24 ET
|
|
Tria Beauty, Inc. and Sephora Announce New U.S. Retail Partnership
|
Wed Mar 13 2013, 7:14 ET
|
|
SafeCode Drug Technologies Acquires Breakthrough Painless Injection Technology
|
Tue Mar 12 2013, 9:13 ET
|
|
FDA Grants Chimerix Fast Track Designation for CMX001 for the Prevention of Clinically Significant Cytomegalovirus Infection
|
Tue Mar 12 2013, 7:00 ET
|
|
invendo medical Announces US Market Entry Following Special 510(k) Clearance By FDA For Computer-Assisted Single-Use Colonoscopy System
|
Mon Mar 11 2013, 6:00 ET
|
|
Ampio Receives FDA Acceptance of its Patient Outcome for Premature Ejaculation (POPE) Questionnaire, Paving the Way for its US Pivotal Trial on Zertane™
|
Mon Mar 11 2013, 4:00 ET
|
|
Food Micro-Fifth Edition: Microbiology Testing in the US Food Industry
|
Fri Mar 8 2013, 12:53 ET
|
|
Wake Forest Innovations Announces New Commercialization Developments
|
Fri Mar 8 2013, 10:16 ET
|
|
Actavis Confirms Generic Exelon® Patch Patent Challenge
|
Fri Mar 8 2013, 8:30 ET
|
|
InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
|
Thu Mar 7 2013, 17:52 ET
|
|
Galectin Therapeutics Inc. Receives OK from FDA to Proceed with First Human Clinical Trial for Treatment of Fatty Liver Disease with Advanced Fibrosis
|
Tue Mar 5 2013, 9:00 ET
|
|
Tenaxis Medical®, Inc. Receives FDA Approval for its ArterX® Surgical Sealant
|
Mon Mar 4 2013, 20:31 ET
|
|
FDA Issues Complete Response Letter for XARELTO® (rivaroxaban) for the Reduction of Cardiovascular Events in Patients with Acute Coronary Syndrome
|
Mon Mar 4 2013, 18:30 ET
|
|
FDA Clears First Blood Glucose Monitoring System To Automatically Send Results Wirelessly Via Bluetooth® Technology to iOS Devices
|
Mon Mar 4 2013, 14:34 ET
|
|
Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
|
Mon Mar 4 2013, 7:00 ET
|
|
DMH International Announces FDA Approval of TouchPACS
|
Fri Mar 1 2013, 9:20 ET
|
|
Philips receives FDA clearance to market MicroDose SI mammography system
|
Thu Feb 28 2013, 14:29 ET
|
|
CSL Behring Receives FDA Approval to Expand the Indication for Corifact®
|
Thu Feb 28 2013, 9:00 ET
|
|
SynCardia's 50cc Total Artificial Heart Receives Two HUD Designations from the FDA for Destination Therapy and Pediatric Bridge to Transplant
|
Thu Feb 28 2013, 7:55 ET
|
|
U.S. ARKRAY Announces FDA Clearance of the Fully Automated Integrated Urine Analyzer AUTION HYBRID™ AU-4050
|
Thu Feb 28 2013, 6:00 ET
|
|
Cardioviva™ Heart Health Probiotic Achieves FDA Generally Recognized As Safe (GRAS) Status
|
Wed Feb 27 2013, 13:44 ET
|
|
Recall of Anemia Drug Omontys Rings Alarm Over Biosimilars
|
Wed Feb 27 2013, 11:57 ET
|
|
Surgical Theater, LLC™ Receives FDA Clearance for Surgery Rehearsal Platform™
|
Wed Feb 27 2013, 11:09 ET
|
|
Syneron Beauty Introduces the me smooth At-Home Hair Removal System
|
Wed Feb 27 2013, 6:23 ET
|
|
Shionogi Receives FDA Approval For Osphena™ (Ospemifene) For The Treatment Of Dyspareunia, A Symptom Of Vulvar And Vaginal Atrophy (VVA), Due To Menopause
|
Tue Feb 26 2013, 15:10 ET
|
|
Tandem Diabetes Care Announces FDA Clearance of t:connect Diabetes Management Application for Use with t:slim Insulin Pump
|
Tue Feb 26 2013, 9:00 ET
|
|
Bayer's Stivarga® (regorafenib) Tablets Approved by U.S. FDA for Treatment of Patients with Locally Advanced, Unresectable or Metastatic GIST
|
Mon Feb 25 2013, 16:05 ET
|
|
Actavis' Generic Suboxone® Receives FDA Approval
|
Mon Feb 25 2013, 7:30 ET
|
|
Lupin Receives FDA Approval for New Drug Application for SUPRAX® Oral Suspension, 500 mg/5mL
|
Fri Feb 22 2013, 8:20 ET
|
|
Lupin Receives FDA Approval for New Drug Application for SUPRAX® Oral Suspension, 500 mg/5mL
|
Fri Feb 22 2013, 8:20 ET
|
|
CSL Behring Announces New Vial Size of Privigen® for Treatment of Primary Immunodeficiency and Chronic Immune Thrombocytopenic Purpura
|
Thu Feb 21 2013, 9:00 ET
|
|
FDA Publicly Challenged to Support Unsubstantiated Claims Regarding Electronic Cigarettes
|
Wed Feb 20 2013, 8:00 ET
|
|
UCB Announces Regulatory Filings for Cimzia® (Certolizumab Pegol) to Treat Psoriatic Arthritis and Axial Spondyloarthritis
|
Wed Feb 20 2013, 7:00 ET
|
|
Perfect Your Physique
|
Tue Feb 19 2013, 9:30 ET
|
|
InSightec's ExAblate Neuro Receives the Go-ahead from FDA to Begin its Pivotal Phase III trial for Essential Tremor
|
Tue Feb 19 2013, 9:21 ET
|
|
Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%
|
Tue Feb 19 2013, 9:19 ET
|
|
Epiduo® Gel Becomes First Topical Prescription Acne Treatment Available For Children As Young As 9 Years Old
|
Tue Feb 19 2013, 9:00 ET
|
|
ElectroCore® Receives Australian and Colombian Regulatory Approval for GammaCore® Vagal Nerve Stimulation Therapy
|
Tue Feb 19 2013, 9:00 ET
|